Table 5.
Mean | SD | Min | Max | BFCondition | p condition | ||
---|---|---|---|---|---|---|---|
Age | Placebo | 28.85 | 10.46 | 19 | 54 | 0.384 | 0.701 |
Propranolol | 27.54 | 6.12 | 19 | 42 | |||
SPQ | Placebo | 24.15 | 3.98 | 16 | 30 | 0.485 | 0.384 |
Propranolol | 22.92 | 3.04 | 18 | 27 | |||
ASI | Placebo | 7.77 | 5.29 | 2 | 19 | 0.580 | 0.269 |
Propranolol | 10.15 | 5.46 | 3 | 22 | |||
PHQ | Placebo | 2.69 | 1.49 | 1 | 6 | 0.636 | 0.227 |
Propranolol | 3.46 | 1.66 | 1 | 6 | |||
STAIT | Placebo | 34.65 | 7.61 | 25 | 51 | 0.420 | 0.537 |
Propranolol | 36.42 | 6.76 | 26 | 49 | |||
Contingency: | |||||||
M:F | Bayes Factor | p -value | |||||
Sex | Placebo | 1:12 | 0.944 | 0.227 | |||
Propranolol | 3:10 |
BFCondition, Bayes factor for inclusion of condition in ANOVA; p condition, p-value for difference between groups in ANOVA.